Rethinking Clinical Trials

JULY 22, 2022

Associate Vice President, Research Partnerships. The normal timeline for public-private partnerships is around 9 months of planning. ACTIV was stood up in about a month, launching on April 17, 2020, to develop a coordinated research response to speed COVID-19 treatment and vaccine options. Foundation for the NIH. Key Points.

Vaccination 130

Vaccination Vaccine Clinical Trials Clinical Trials 130

Pharmaceutical Technology

MAY 1, 2023

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. Shunxi will also hold an option to negotiate rights to other CAR-T products, which include the licenced IP.

Gene Therapy 130

Gene Therapy Gene Development Clinical Trials 130

Rethinking Clinical Trials

SEPTEMBER 30, 2022

The home visit services were covered through a Medicaid waiver that allowed the Nurse Family Partnership (NFP) to serve about 4,000 people over 4 years (up to 40 visits at home). This was a randomized controlled trial that enrolled 5,670 mothers into the evaluation between 2016 and 2020, with 2/3 allocated to the intervention group.

Nurses 130

Nurses Trials Clinical Trials Clinical Trials 130

XTalks

FEBRUARY 27, 2024

In 2020, 31 out of 53 novel drug approvals were for rare or orphan diseases​​. Skyclarys (omobaloxone) was approved in 2023 for the treatment of adults and pediatric patients 16 years of age and older with Friedreich’s ataxia, a rare, neurological disease​​. Both therapies were awarded their approvals on the same day in December 2023.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Virtual connections. Engagement channels.

Regulation 97

Regulation Marketing Sales Branding 97

XTalks

JUNE 9, 2021

The historic and highly anticipated approval created a flurry of excitement in the Alzheimer’s disease space for patients, healthcare practitioners, advocacy groups and Biogen shareholders alike, as shares of the company jumped more than 50 percent after the announcement. Aducanumab Controversy and Price Tag.

Drugs 98

Drugs Clinical Trials Clinical Trials Trials 98

XTalks

MARCH 22, 2023

And in 2020, AbbVie bought out Allergan for $63 billion, four years after Allergan and Pfizer abandoned their planned megamerger after a years-long will-they-or-won’t-they courtship. No matter how you’re looking to communicate your expertise in the life sciences, your audience is already here, so contact us to become an Xtalks partner.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97